Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2003 February;55(1) > Minerva Pediatrica 2003 February;55(1):23-32

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

REVIEWS  


Minerva Pediatrica 2003 February;55(1):23-32

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: Italian

Celiac disease. A world in exploration

Fornaroli F., Drago S., Di Pierro M. R., Catassi C., Fasano A.


PDF  


Celiac disease (CD) or gluten-sensitive enteropathy is an autoimmune disorder triggered by gluten ingestion in genetically predisposed subjects. The presence of gluten in these patients leads to a self-perpetuating mucosal damage, while the elimination of gluten results in a full mucosal recovery. The prevalence of CD in the general population is between 0.3% and 1%. The clinical manifestation of CD is variable; in addition to the classical gastrointestinal form a variety of other clinical manifestation of the disease have been described, including atypical and asymptomatic form. The diagnosis of CD is still based on the small intestinal biopsy findings, but can be suspected using serological testing, e.g. the antigliadin antibody (AGA), the antiendomysial antibody (EMA) and the anti-tissue transglutaminase antibody (tTG). The keystone treatment of CD patients is a life-long gluten-free diet.

top of page

Publication History

Cite this article as

Corresponding author e-mail